Bond.az White LogoBond.az Black Logo

BofA cuts Li Auto price target on lower sales forecast

BofA Securities lowered Li Auto's price target from $22 to $18 due to reduced sales forecast. Neutral rating maintained.

Daniel Rodriguez
ByDaniel Rodriguez- Senior Editor
|
0

Bond.az reports that BofA Securities lowered its price target on Li Auto Inc. (NASDAQ:LI) to $18.00 from $22.00 while maintaining a Neutral rating. The stock currently trades at $15.47, near its 52-week low of $15.29, and has declined 43% over the past year.

Bond.az data suggests the stock appears undervalued at current levels. The firm reduced its forecast after Li Auto guided for 95,000 to 100,000 vehicle deliveries in Q2 2026, representing a 4.5% to 10% year-over-year decline. The company projected Q2 revenue of RMB 24.1 billion to RMB 25.4 billion, down 16% to 20% year-over-year.

BofA Securities cut its 2026 and 2027 volume sales estimates by 5% each. The firm also lowered its 2026 gross profit margin forecast by 0.8 percentage points and its 2027 margin estimate by 0.1 percentage points.

The firm expects Li Auto to record a RMB 2.7 billion non-GAAP net loss in 2026. The new price target of $18 per ADS, or HKD 70, reflects lower sales and margin projections.

In other news, Li Auto reported Q1 2026 revenue of RMB 23.0 billion, exceeding analyst expectations, but a larger-than-anticipated loss per share.

More News
2026-06-01 12:02
|
743

Legend Biotech Buy Rating Reiterated

H.C. Wainwright reiterated its Buy rating for Legend Biotech with a $50 target. Revenue up 56% over twelve months.

0
2026-06-01 12:01
|
475

Cogent Stock Price Target Raised to $55

Cogent Biosciences PEAK trial: combination therapy shows 45.6% response rate, 16.5 months PFS, FDA accepts NDA. H.C. Wainwright raises price target to $55.

0
2026-06-01 12:00
|
842

H.C. Wainwright Reaffirms Mineralys Buy

H.C. Wainwright reiterated a Buy rating on Mineralys Therapeutics with a $56 price target after positive trial data.

0
2026-06-01 10:33
|
714

Goldman Sachs Upgrades Marriott Vacations Stock

Goldman Sachs upgrades Marriott Vacations stock to Buy, price target $100. Execution potential drives earnings upside.

0
2026-06-01 10:32
|
731

Goldman Sachs Upgrades Travel + Leisure Stock to Buy

Goldman Sachs upgraded Travel + Leisure stock to Buy with a $85 price target. Learn about the company's financials, dividends, and market outlook.

0
2026-06-01 10:32
|
238

Canaccord Initiates Rare Earths Americas with Buy

Canaccord Genuity initiates Rare Earths Americas with a buy rating and $25 target. Stock at $21.85, offering 14% upside potential.

0
2026-06-01 10:30
|
651

BofA Raises Icon Stock Target to $125 on Bookings

BofA Securities raised Icon plc price target to $125, maintains Underperform. Improved booking trends and Q4 results drive revision.

0
2026-06-01 10:03
|
748

RBC Capital: Sprouts faces Kroger risk

RBC Capital keeps Sprouts rating but sees risks from Kroger price cuts. Analysis and outlook on Bond.az.

0
2026-06-01 09:02
|
551

CLSA Rates Chagee Hold on Margins

CLSA initiated Chagee Holdings with Hold rating and $10 target. Bond.az analysis reveals stock may be undervalued. Read more.

0
2026-06-01 08:31
|
594

Barclays Downgrades Sensata Stock on Valuation

Barclays downgrades Sensata stock to Equalweight on valuation concerns, but raises price target to $53. Stock surged 92% in past year.

0
2026-06-01 08:05
|
946

UBS Initiates Veritone Coverage with Neutral

UBS initiated coverage on Veritone with a Neutral rating and $2.50 price target. The AI company is better positioned for growth after transformation.

0
2026-06-01 08:02
|
892

JMP Securities Initiates Microsoft with Outperform on AI Strategy

JMP Securities initiates Microsoft with Market Outperform rating and $550 target on AI strategy. Revenue growth expected to reach 17% in FY2026.

0
...
BofA cuts Li Auto price target on lower sales forecast | Bond.az